Company Description

Adaxion Therapeutics is a biotechnology company focused on developing novel therapeutic strategies, particularly in the area of immunotherapies. Their ADAx platform is an innovative technology that incorporates proprietary CD22 ligands (CD22L) on biologics to target and suppress therapeutic-specific B cells, while preserving the full functionality of the biologic.